Persistence of the mitochondrial permeability transition in the absence of subunit c of human ATP synthase. by He, Jay et al.
 1 
Re-revised manuscript 
Persistence of the mitochondrial permeability transition in the 
absence of subunit c of human ATP synthase 
Jiuya He, Holly C. Ford, Joe Carroll, Shujing Ding, Ian M. Fearnley and 
John E. Walker 
The Medical Research Council Mitochondrial Biology Unit, Cambridge Biomedical Campus, 
Hills Road, Cambridge CB2 0XY, United Kingdom 
*To whom correspondence should be addressed. J. E. W., Tel.: +44-1223-252701; e-mail: 
walker@mrc-mbu.cam.ac.uk 
Running title: The mitochondrial permeability transition pore 
The authors declare no conflict of interest 
Author contributions: J. E. W. designed research and supervised project; J. H., H. F., J. C., S. 
D. and I. M. F. performed research; J. H., H. F., J. C., S. D., I. M. F. and J. E. W. analysed data, 
and J. E. W. prepared the manuscript  
Classification: BIOLOGICAL SCIENCES, Biochemistry 
Key words: human mitochondria; ATP synthase; permeability transition pore; subunit c  
  
 2 
Abstract 
The permeability transition in human mitochondria refers to the opening of a non-specific 
channel, known as the permeability transition pore (PTP) in the inner membrane. Opening can 
be triggered by calcium ions, leading to swelling of the organelle, disruption of the inner 
membrane and ATP synthesis, followed by cell death. Recent proposals suggest that the pore 
is associated with the ATP synthase complex, and specifically with the ring of c-subunits that 
constitute the membrane domain of the enzyme’s rotor. The c-subunit is produced from three 
nuclear genes, ATP5G1, ATP5G2 and ATP5G3, encoding identical copies of the mature 
protein with different mitochondrial targeting sequences that are removed during their import 
into the organelle. To investigate the involvement of the c-subunit in the PTP, we generated a 
clonal cell, HAP1-A12, from near-haploid human cells, in which ATP5G1, ATP5G2 and 
ATP5G3 were disrupted. The HAP1-A12 cells are incapable of producing the c-subunit, but 
they preserve the characteristic properties of the PTP. Therefore, the c-subunit does not provide 
the PTP. The mitochondria in HAP1-A12 cells assemble a vestigial ATP synthase, with intact 
F1-catalytic and peripheral stalk domains and supernumerary subunits e, f and g, but lacking 
membrane subunits ATP6 and ATP8. The same vestigial complex plus associated c-subunits 
was characterized from human 143B ρ0 cells, which cannot make subunits ATP6 and ATP8, 
but retain the PTP. Therefore, none of the membrane subunits of the ATP synthase that are 
involved directly in transmembrane proton translocation is involved in forming the PTP. (246 
words). 
Significance  
Cellular power houses called mitochondria generate fuel known as adenosine triphosphate, or 
ATP, to sustain complex life. The capacity of mitochondria to do so depends on a supply of 
energy from oxidation of energy rich compounds in food-stuffs to generate a chemical potential 
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difference for hydrogen ions, called the proton motive force (pmf), across the inner of their two 
membranes. Disruption of this membrane dissipates the pmf, and the cells die for lack of fuel. 
This event happens, for example, when the concentration of calcium ions inside human 
mitochondria is increased. The mitochondria respond by opening a pore, water enters, the 
mitochondria swell and burst. The molecular identity of the pore is disputed, and we have 
disproved one proposal. (119 words) 
Introduction 
The inner membranes of mitochondria contain a high conductance non-specific channel, 
known as the permeability transition pore (or PTP), which opens in response to elevated 
concentrations of Ca2+ in the mitochondrial matrix (1). Opening of the pore is potentiated by 
inducers such as phosphate, adenine nucleotide depletion and thiol oxidants, and leads to the 
swelling of the mitochondria, loss of proton motive force (pmf), disruption of ion homeostasis 
and hydrolysis of ATP by the ATP synthase (2). These events have been linked to pathways 
leading to cell death, and to human diseases including cardiac ischemia and muscle dystrophy 
(3). The opening of the pore can be induced artificially by compounds such as thapsigargin, a 
non-competitive inhibitor of the Ca2+-ATPase in the sarcoplasmic and endoplasmic reticula 
(4), and by ionophores for divalent cations such as ferutinin (5). It can also be inhibited by 
drugs such as cyclosporin A, mediated via its binding to the prolyl cis-trans isomerase, 
cyclophilin D, in the mitochondrial matrix (6, 7). 
Since the discovery of the mitochondrial permeability transition, many proposals have 
been made about the protein constituents of the PTP itself, including the ADP/ATP translocase, 
an abundant component of the inner membranes of mitochondria, and the voltage dependent 
anion channel found in the outer membranes of the organelle, but none of these proposals has 
been established definitively (8, 9). Recently, it has been proposed that the PTP is associated 
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with another abundant component of the inner mitochondrial membrane, the ATP synthase 
complex (10). The monomeric mammalian ATP synthase is a multiprotein assembly made of 
eighteen different protein subunits (11). The enzyme consists of two major domains, a 
membrane intrinsic sector and a membrane extrinsic F1-sector, joined together by central and 
peripheral stalks (11). In mitochondria, the monomeric complexes form dimers via interactions 
between their membrane domains, and the dimers associate in rows along the edges of the 
cristae (12, 13). The membrane domain of each monomer contains a rotary motor driven by 
the pmf produced by respiration. The membrane embedded part of the rotor is a ring of eight 
c-subunits in the bovine enzyme (14). Since the sequences of the bovine and human c-subunits 
are identical, it is reasonable to assume that the human c-ring is identical. In the intact enzyme, 
the external surface of this ring is in contact with a single ATP6 (or a) subunit (15–18). During 
ATP synthesis, the c8-ring turns with estimated speeds of up to 300 Hz. The generation of 
rotation involves the translocation of protons across the membrane domain of the enzyme via 
a pathway at the interface between the surface of the c-ring and subunit ATP6. The rotational 
energy of the rotor is transmitted to the catalytic domain by the central stalk, which is a 
membrane extrinsic structure attached firmly to the c-ring. The central stalk consists of single 
copies of the γ-, δ- and ε-subunits and lies along the central axis of the F1 domain, surrounded 
by the α3β3-catalytic domain, a hexameric structure of alternating α- and β-subunits. At three 
of the six α-β-interfaces are found the catalytic sites of the enzyme, where ATP is formed from 
ADP and inorganic phosphate, using energy supplied by rotation (19, 20). In the absence of a 
proton-motive force, the F1-ATPase inhibitor protein, IF1, prevents the hydrolysis of ATP by 
binding to one of the catalytic interfaces (21). The main role of the peripheral stalk, a 
predominantly α-helical structure made from single copies of the oligomycin sensitivity 
conferral protein (OSCP), and subunits b, d and factor 6 (F6) (22–24) is to link the α3β3 domain 
to subunit ATP6, which interacts with the two predicted trans-membrane α-helices of the b-
 5 
subunit, so that together the α3β3 domain, the peripheral stalk and subunit a form the stator of 
the enzyme (11, 18). The membrane domain of the mammalian ATP synthase also contains six 
other proteins e, f, g, DAPIT (diabetes associated protein in insulin sensitive tissues), 6.8PL 
(6.8 kDa proteolipid) and ATP8 (or A6L) (25–29). They are known collectively as the 
"supernumerary" subunits, and with the exception of ATP8, they appear to have no direct role 
in the synthesis of ATP. They are all localised in the vicinity of the region of interaction 
between monomers in the dimeric complex. Each is predicted to contain a single 
transmembrane α-helical span (30). Subunits ATP6 and ATP8 are the only components of the 
complex that are encoded in the mitochondrial genome (25); all the other subunits of the human 
complex are the products of single nuclear genes, except for subunit c which is encoded by 
three genes, ATP5G1, ATP5G2 and ATP5G3 (31, 32) (Fig. S1). Their gene products differ 
only in the sequences of their N-terminal regions, which direct the protein from the cellular 
cytoplasm to the inner mitochondrial membrane, and are removed by proteolysis to generate 
the same identical mature c-subunit found assembled in ATP synthase complexes.  
If the PTP is associated with the ATP synthase complex, it is likely that it will involve 
one or more of the membrane subunits, and one proposal that has been made is that the c8-ring 
of the human ATP synthase provides the mitochondrial PTP (33–35). In order to test this 
proposal, as described here, we have disrupted ATP5G1, ATP5G2 and ATP5G3 together in a 
single clone of a near-haploid human cell line, and investigated whether the PTP, which is 
present in the parent HAP1 cells, persists in the mutant cells devoid of subunit c. 
Results 
Characteristics of wild-type HAP1 cells. HAP1 cells have a haploid karyotype except for a 
fragment of chromosome 15 which is located in chromosome 19, and they also contain a 
reciprocal translocation between chromosomes 9 and 22 (36, 37). None of these features affects 
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the structures of the three genes ATP5G1, ATP5G2 and ATP5G3 encoding the three different 
precursors of the c-subunit of ATP synthase, which are found, respectively, on the single copy 
chromosomes 17, 12 and 2. All three genes are transcribed in HAP1 cells, but ATPG3 is 
expressed predominantly with about 75% of the transcripts arising from this gene (Fig. S2). 
Human cells devoid of subunit c. In a clonal HAP1 cell line the ATP5G1, ATP5G2 and 
ATP5G3 genes were disrupted. Three pairs of guide RNAs (gRNAs), each pair specific for one 
of the exons IV in ATP5G1 or ATP5G2, or for exon III in ATP5G3, were introduced together 
into the cells (Fig. S1; Table S1). Clones arising from single cells, identified as having 
expressed Cas9, were screened for the presence of the c-subunit by western blotting. By this 
means, clone HAP1-A12 was found to be devoid of subunit c (Fig. 1). Analysis of DNA 
sequences (Table S2) in regions of its genome where ATP5G1 and ATP5G2 are found showed 
that deletions of 140 and 97 bases, respectively, had been introduced into exons IV in ATP5G1 
and ATP5G2 (Fig. S3A and B). Each had arisen from two gRNAs and non-homologous end-
joining (NHEJ) (38) of the deleted genomic DNA. The deletion in ATP5G1 changed the 
sequence of the precursor of subunit c immediately before the precursor cleavage site and 
introduced an unrelated sequence of eighteen amino acids which then terminated, and that in 
ATP5G2 changed the frame of the coding region in the import sequence, leading to an altered 
protein sequence four amino acids before the junction with the mature protein, and truncation 
of the frame-shifted protein nine amino acids thereafter. Sequencing of ATP5G3 showed that 
gRNA ATP5G3-1 had been targeted successfully to the gene whereas ATP5G3-2 had not 
(Table S1), and a four base deletion had been introduced into the gene by NHEJ. This deletion 
changed the frame of the encoded protein in the import precursor region, producing a frame 
shifted protein ten amino acids before the junction between the import sequence and the mature 
protein, which terminated fourteen amino acids later (Fig. S3C). Thus, none of the three 
disrupted genes in the HAP1-A12 clone was capable of producing a protein containing any of 
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the sequence of the mature c-subunit. 
Characteristics of HAP1-A12 cells. The co-disruption of ATP5G1, ATP5G2 and ATP5G3 
and the accompanying removal of the c-subunit, slightly diminished the ability of the HAP1-
A12 cells to grow relative to the wild-type cells (Fig. 2A), and it was accompanied by an 
increase in the copy number of mitochondrial DNA molecules by about 50% (Fig. 2B). 
However, the HAP1-A12 cells have a lower respiratory activity (Fig. 2C), which is sufficient 
to allow them to maintain a mitochondrial membrane potential in the absence of an active ATP 
synthase (Figs. 2D and 2E). The mitochondria respire using the substrates glutamate/malate 
and succinate, confirming the presence of active respiratory complexes. The lower initial 
TMRM signal for HAP1-A12 sample suggests that the mitochondria may be less leaky to 
protons in the absence of the c-subunit, such that a partial membrane potential can be 
maintained during the preparation. As expected, there was no impact of oligomycin on either 
respiration or the membrane potential in HAP1-A12 cells. 
The mitochondria of wild-type HAP1 cells and HAP1-A12 cells were stained to the 
same extent with both TMRM and calcein (Fig. S4) allowing treated cells to be normalised 
with untreated wild-type cells in subsequent experiments. In order to verify that the 
mitochondria of HAP1 wild-type cells contain a PTP, the opening of the pore was demonstrated 
in intact cells in the presence of both thapsigargin and the calcium ionophore ferutinin. For 
both reagents, the optimum conditions leading to complete opening of the PTP were established 
(Fig. 3A). With both reagents, the opening of the PTP was prevented by cyclosporin A. Similar 
results were obtained with HAP1-A12 cells (Fig. 3B). In other experiments with HAP1 and 
HAP1-A12 cells where their plasma membranes had been permeabilized with digitonin, the 
responses of the cells to successive pulses of Ca2+ in the absence and presence of cyclosporin 
A were monitored (Fig. 4, and Tables S3 and S4). On average, the ratios of the number of 
calcium pulses required to induce the PTP in the presence and absence of CsA were similar; 
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the values were 2.89±0.62 (n=9) in wild-type cells, and 2.48±0.36 (n=4) in HAP1-A12 cells. 
In HAP1-ΔPPIF cells, which lack cyclophilin D, the value was 0.97±0.07 (n=4) for the clone 
presented in Fig. 4, and 0.99±0.20 (n=3) for a second clone (data not shown). Thus, in response 
to pulses of exogenous Ca2+, there was no significant difference in pore opening in the presence 
and in the absence of subunit c. As expected, disruption of PPIF had removed the sensitivity 
of the pore to cyclosporin A in HAP1 cells, and, in both wild-type and HAP1-A12 cells, 
inhibition of the mitochondrial calcium uniporter immediately after a single calcium injection 
prevented any further uptake of Ca2+ by mitochondria (Figs. 5C and F). 
Characterization of the vestigial ATP synthase in HAP1-A12 and ρ0 cells. Despite the 
significant effect of the removal of subunit c on cellular respiration, the mitochondria of HAP1-
A12 cells retain an assembled vestigial ATP synthase complex. This complex, examined by 
SDS-PAGE analysis (Fig. 5A), and by quantitative mass spectrometry of the subunits of the 
purified complex (Figs. 5B and S5, and Tables S5 and S6), contained a complete complement 
of subunits of the F1-catalytic domain (subunits α, β, γ, δ and ε) and the peripheral stalk (the 
OSCP, and subunits b, d and F6. It also retained supernumerary membrane subunits e, f and g, 
but lacked DAPIT and the mitochondrially encoded subunit ATP6. The analyses suggested 
also that subunits ATP8 and 6.8PL were absent from the vestigial complex (see Fig. 5A). In 
contrast, the abundance of one mature form of IF1, IF1-M1 (see Fig. S6) found in association 
with the vestigial complex, had increased by 7-13 fold relative to the wild-type complex. 
The mitochondria from human 143B ρ0 cells also retain a vestigial ATP synthase 
complex resembling the vestigial enzyme complex in HAP1-A12 cells (Figs. 5 and S5, and 
Tables S7 and S8). It also has a full complement of subunits in the catalytic F1 and peripheral 
stalk domains, plus supernumerary subunits e, f and g. The levels of DAPIT and 6.8PL were 
found to have diminished in mitoplasts relative to wild-type cells (Fig. S5, Table S11), and still 
more in the purified complex (Fig. S5, Table S7), implying that they are weakly associated 
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with the complex, and partially lost during its extraction and purification. The relative 
abundance of the IF1-M1 form of the inhibitor protein (Fig. S6A) associated with the vestigial 
complex had increased slightly. However, in ρ0 cells the mitochondrial import precursor of the 
inhibitor protein, IF1-P (see Fig. S6A) was increased by 34-fold relative to parent cells. The 
presence of IF1-P in the mitochondria of ρ0 cells has been noted before (39). These 
mitochondria also have an active PTP, as reported before (40) and confirmed here, where 
opening could be stimulated by either ferutinin or thapsigargin and inhibited by cyclosporin A 
(Fig. S7). Therefore, these experiments with HAP1-A12 and 143B ρ0 cells together show that 
subunit c, and also ATP6 and ATP8 are not involved in forming the PTP. An additional more 
tentative conclusion is that subunits DAPIT and 6.8PL of the ATP synthase are also not part 
of the PTP.  
Oligomeric state of vestigial ATP synthases. The permeability transition pore has been 
proposed to be associated with dimers, and not monomers of the ATP synthase complex (10, 
41). Therefore, the oligomeric state(s) of the vestigial complexes in HAP1-A12 and 143B ρ0 
cells were investigated by extraction of the complexes with digitonin, and native gel 
electrophoresis of the extract (Fig. 6). Under the conditions employed for the extraction of the 
complexes from mitoplasts from HAP1-A12 cells for native gel analysis, the vestigial ATP 
synthase contains two or three related sub-complexes with a smaller apparent molecular weight 
than the intact monomeric ATP synthase complex (Fig. 6A). Thus, this gel seemed to indicate 
that the “complex” from HAP1-A12 cells is a mixture of related complexes. This conclusion 
is not supported by the SILAC data which strongly indicate that it is a single complex (Fig. 5), 
and that therefore the multiple bands on the native gel are artefactual. It is likely that the 
removal of the c-ring and accompanying loss of subunits ATP6 and ATP8 destabilises the 
dimerization interface, which probably relies on subunits e and g, and may also depend on 
supernumerary subunits f, DAPIT and 6.8PL (17, 18). It is also possible that the vestigial 
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complex remains dimeric in the membrane and that it is destabilised (monomerised) 
artefactually by the extraction process. The dependency of the oligomeric state of the ATP 
synthases and vestigial complexes on conditions for their extraction from mitoplast is 
illustrated by the analysis of the vestigial complex from 143B ρ0 cells (Fig. 6B). At the lower 
concentration of digitonin, the extract contains species corresponding to dimers and monomers 
of the enzyme, and at the higher concentration of digitonin, monomers and smaller sub-
complexes.  
Discussion 
The experiments described above with HAP1-A12 cells show conclusively by three 
independent assays of the PTP that, even when the c-protein is absent from their mitochondria, 
the cells retain a PTP. In intact cells, it opens characteristically in response to treatment with 
either thapsigargin or ferutinin, and in permeabilized cells in response to elevated 
concentrations of extramitochondrial Ca2+. In all of these assays, opening of the pore can be 
inhibited by cyclosporin A. Therefore, the c-ring is not an essential component of the PTP.  
Even before these experiments were carried out, a number of features of human c8-rings 
were apparent that seemed to be incompatible with the presence in the rings of a non-specific 
aqueous channel capable of passing hydrophilic molecules with a molecular weight up to 1500 
Da (1, 42), as a description of the ring illustrates. The sequence of the identical human and 
bovine mature c-subunits is 75 amino acids long. In the structure of the bovine c-ring (14), 
residues 4-37 and 44-74 of each c-subunit are folded into two antiparallel α-helices, arranged 
respectively in inner and outer rings. The two α-helices in each subunit are joined by extended 
polar loops from residues 38-43, in the lipid head group region on the matrix side of the inner 
membrane. Each loop region contains an arginine residue at position 38 and a fully 
trimethylated lysine residue at position 43 (43). The N-terminal regions extend towards the 
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space between inner and outer membranes of the organelle, and each has aspartic acid residues 
at positions 1 and 3, and an unmodified lysine at position 7. Residues in the polar loops and 
the N-terminal extensions attract cardiolipin molecules selectively over phospholipids (44). 
With the exception of glutamate-58 on the outer surface of the ring, which plays a central role 
in the pathway for membrane translocation of protons, the outer surface of the ring is almost 
entirely hydrophobic, in keeping with its contact with the hydrophobic environment of the inner 
mitochondrial membrane. The inner surface of the ring is also almost entirely hydrophobic, 
with the exception of an accessible threonine residue at position 27 (Fig. S8), and it is likely 
that the central cavity of the mitochondrial c-ring is occupied by lipids, as demonstrated in the 
related spinach chloroplast c14-rings and the c-ring from Escherichia coli (45, 46).  
A second structural feature that tends to argue against the c-ring functioning as the PTP 
is that, in the intact enzyme, access to the central cavity of the c-ring from the matrix side of 
the membrane is impeded, and possibly completely blocked, by the association of the foot of 
the central stalk with the c-ring (14) (Fig. S8). At its narrowest point, approximately in the 
middle of the lipid bilayer, the cavity has a diameter of about 4 Å, widening in both directions 
to about 12 Å at the external surfaces. The interaction between the c-ring and the central stalk 
provides a crucial connection between the membrane intrinsic and membrane extrinsic parts of 
the rotor of the ATP synthase that has to be sufficiently robust to resist the rotational torque of 
the motor turning at up to 300 Hz. In the structure of the bovine F1-c8 complex, the interacting 
region involves loop regions from five of the c-subunits, and regions of the γ-, δ- and ε-subunits 
(Fig. S8). The interface is extensive and has a buried surface area of greater than 790 Å2. 
However, the positions of amino acid side chains in the interface are uncertain, and for that 
reason they have not been introduced into the structural model. If they were, it is likely that 
most or all of the small apparent crevice in the interface region leading to the central cavity 
would be blocked entirely. 
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One possible way of exposing the central cavity would be to release the central stalk 
and α3β3-domain, leaving the intact membrane domain with a central cavity freely accessible 
from both sides of the membrane. In the related V-ATPases, such a physiological mechanism 
exists as a way of regulating the activity of the enzyme, and a free Vo membrane domain 
containing the equivalent of the c-ring is produced by the dissociation of the V1 catalytic 
domain (47, 48). However, a similar mechanism has not been demonstrated in the 
mitochondrial F-ATP synthases, and the hydrolytic activity of the enzyme is regulated by a 
different mechanism involving the inhibitor protein, IF1 (21). In the purified enzyme and in 
everted inner membrane vesicles, the interface between the F1 and membrane domains is 
resistant to dissociation, for example by mild detergents and mild chaotropes, or by elevated 
salt concentrations. The only known biochemical way of removing the catalytic domain from 
membranes so as to leave the membrane domain intact is to dissociate the membrane extrinsic 
proteins with strong chaotropes such as sodium bromide or guanidinium hydrochloride, leaving 
the membrane domain of the enzyme intact and protected by the lipid bilayer (49). The only 
patho-physiological circumstance where isolated human c-rings have been observed is in 
insoluble storage bodies derived from lysosomes associated with ceroid lipofuschinosis, or 
Batten’s disease (50). Here, the accumulation of c-rings in the storage bodies appears to be 
derived from defects in a lysosomal pathway for degradation of the c-protein (51). 
A somewhat surprising corollary of the demonstration of the PTP in HAP1-A12 cells 
is that in the absence of subunit c, a vestigial ATPase complex, containing the catalytic and 
peripheral stalk domains and supernumerary subunits e, f and g, is still assembled in the 
mitochondria (Fig. 5). However, the vestigial complex and the mitoplasts from which it is 
derived also lack subunit ATP6. Therefore, neither the proton translocation pathway at the 
interface of the c-ring and ATP6, nor ATP6 itself, is associated with the PTP. The presence of 
the PTP in ρ0 cells, which lack mitochondrial DNA and the encoded ATP6 and ATP8 subunits, 
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has been noted before (40), and the vestigial F-ATPase complexes from HAP1-A12 cells and 
143B ρ0 cells are remarkably similar, except that the latter contains additionally the c-subunit 
(presumably organized in the c8-ring). Thus, the c-ring is not an absolute requirement for the 
assembly of either the F1 or peripheral stalk domains.  
Both vestigial complexes also probably lack supernumerary subunits DAPIT and 
6.8PL, and therefore, they are unlikely to be components of the PTP either. Thus, if the human 
PTP is associated with the ATP synthase complex, the most likely components available to 
form the pore are any or all of the remaining membrane subunits, b, e, f and g. If such a pore 
complex exists, it may not contain any associated F1 subunits, and so the investigation of the 
possible involvement of these subunits in pore formation will require the application of specific 
antibodies and gene disruption approaches to each of the membrane specific subunits of the 
ATP synthase.  
The ATP synthase complex contains a single copy of subunit b with two 
transmembrane α-helices, and is assumed to contain single copies of subunits e, f and g, each 
predicted to have a single transmembrane α-helix. Recent cryo-electron microscopy analyses 
of the ATP synthase complexes suggest that at least subunits e and g are involved in the 
interface between monomers of the ATP synthase in the dimeric complexes (17, 18). The gene 
disruption strategy followed for the c-subunit provides a possible approach towards resolving 
the issue of whether any or all of these subunits are involved in forming the PTP. 
Materials and Methods 
Cell culture. Near-haploid human HAP1 cells (Horizon Discovery) and derived cell lines 
HAP1-A12 and HAP1-ΔPPIF (HZGHC004185c012), where the gene encoding cyclophilin D 
had been disrupted (Horizon Discovery) were grown at 37oC in the presence of 5% carbon 
dioxide in Iscove’s modified Dulbecco’s medium (IMDM) plus 10% (v/v) fetal bovine serum 
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(FBS). Human osteosarcoma 143B cells (ATCC CRL-8303) were grown under similar 
conditions in Dulbecco’s Modified Eagle’s Medium (DMEM) containing glucose (4.5 g/L) and 
pyruvate (110 mg/L), FBS (10%, v/v), penicillin (100 units/mL) and streptomycin (0.1 
mg/mL). The medium for cultivation of 143B ρ0 cells contained additionally uridine (100 
μg/mL). To determine cell growth rates, initially, 4 x 104 wild-type HAP1 or HAP1-A12 cells 
were plated in triplicate, and estimates of confluence were made with an IncuCyte HD and 
2011A Rev2 software (Essen Bioscience) at 8 h intervals over 4 days. 
The oxygen consumption rate (OCR) of cells was determined with a Seahorse XFe24 
instrument (Agilent Technologies). These measurements were made with cells in XF assay 
medium plus 2 mM glucose and 1 mM pyruvate. 2-Deoxyglucose, oligomycin, carbonyl 
cyanide-4-(trifluoromethoxy)-phenylhydrazone, and a mixture of rotenone and antimycin A, 
were introduced successively at final concentrations of 20 mM, 1 μM, 0.5 μM and 0.6 μM 
each, respectively. 
 The generation of a mitochondrial membrane potential in wild-type HAP1 cells and 
HAP1-A12 cells was monitored in digitonin permeabilized cells (see below) by following the 
fluorescent signal from unbound TMRM (excitation 550 nm/emission 575 nm) with a 
Shimadzu RF-5301PC spectrofluorophotometer. Permeabilized cells were used at a 
concentration of 10 x 106/ml in 2 ml of a solution containing 120 mM KCl, 10 mM NaCl, 1 
mM KH2PO4, 20 mM MOPS-Tris pH 7.2, and 80 nM TMRM. Fluorescence changes were 
measured at 30°C with stirring (500 rpm), following the addition of mitochondrial respiratory 
substrates (5 mM glutamate, 2.5 mM malate, 0.1 mM ADP or 10 mM succinate) and inhibitors 
(1 μM oligomycin, 1 μM rotenone, 1 μM antimycin-A or 1 μM carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone) at the times indicated on the traces. 
Transcription of the ATP5G1, ATP5G2 and ATP5G3 genes. The levels of transcripts for 
the c-subunit from ATP5G1, ATP5G2 and ATP5G3 in HAP1 cells relative to β-actin were 
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estimated by qPCR in an ABI 7900HT Fast Real-Time PCR instrument with specific TaqMan 
gene expression assays and reagents (Thermo Fisher Scientific). 
Disruption of ATP5G1, ATP5G2 and ATP5G3. Three pairs of specific guide RNA 
molecules (gRNAs) directed against exon IV of genes ATP5G1 and ATP5G2 and exon III of 
ATP5G3 were identified and optimised with a design tool for CRISPR (clustered regularly 
interspaced short palindromic repeats; see crispr.mit.edu), synthesised and cloned into the BbsI 
site of plasmid pSpCas9(BB)-2A-GFP (52) (Addgene). This plasmid encodes the CRISPR 
associated protein 9 (Cas9) from Streptococcus pyrogenes separated from the coding sequence 
for the green fluorescent protein (GFP) by a 2A sequence. This arrangement leads to GFP being 
transcribed from the same gene as Cas9, but translated separately from it, allowing cells into 
which Cas9 has been introduced successfully to be separated and enriched in a fluorescence 
activated cell sorter. It also expresses the sgRNA consisting of the gRNA fused to a scaffold 
under the control of the human U6 promoter. The six plasmids (each 0.5 µg) were co-
transfected in the presence of lipofectamine 3000 (Thermo Fisher Scientific) into 40-60% 
confluent HAP1 cells grown in a single well of a six-well plate. Two days later, cells were 
released with trypsin, and resuspended in IMDM containing 10% (v/v) FBS to a density of 1-
2 x 106 cells/mL. Green fluorescent cells were separated into single cells in 96 well plates with 
a High Speed Influx Cell Sorter (BD Biosciences). They were grown at 37oC in the presence 
of 5% carbon dioxide for 2-3 weeks in IMDM plus 10% FBS until single colonies had formed 
in each well. Then they were transferred into 24-well plates, expanded in triplicate, and stored 
at -80oC in IMDM containing 50% (v/v) FBS and 10% (v/v) dimethylsulfoxide.  
Cells in a single well were disrupted for 30 min at room temperature with buffer (100 
μL) containing 10 mM Tris.Cl, pH 7.4, 0.2% (w/v) SDS, 1x cOmplete EDTA-free proteinase 
inhibitor cocktail (Roche) and 0.5 units of benzonase (Merck Millipore). Loading buffer (five 
times normal concentration) was diluted to normal concentration with the sample, and a portion 
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(10-15 μL) was fractionated on a 10-20% acrylamide gradient protein mini-gel (Thermo Fisher 
Scientific). Proteins were transferred electrophoretically onto nitrocellulose membranes, and 
exposed to rabbit antibodies against subunit c (Abcam), and, as loading controls, against 
Tom20 and the β-subunit of ATP synthase (both Santa Cruz Biotechnology). 
The deleted regions of genes were characterized by PCR and DNA sequencing (Source 
Bioscience). Cells in a single well of a 24-well plate were resuspended in a solution (200 μL) 
containing 0.2% (w/v) SDS, 75 mM NaCl, 20 mM EDTA and proteinase K (0.4 mg/mL), and 
the suspension was incubated at 50oC for 2 h. DNA was precipitated with isopropanol, washed 
with 70% (v/v) ethanol, dried, and redissolved in buffer (100 μL) containing 10 mM Tris.Cl, 
pH 8.0. The regions containing exons IV of ATP5G1, ATP5G2 and exon III of ATP5G3 were 
amplified by PCR, and the product sizes analysed by agarose gel electrophoresis. For clone 
A12, the appropriate PCR fragments were cloned with a TOPO TA Cloning Kit (Thermo Fisher 
Scientific), and their DNA sequences were determined. 
Generation of ρ0 cells. 143B cells were cultured for ca. 8 weeks as above, but in the presence 
of ethidium bromide (100 μg/mL) and uridine (100 μg/mL), and then for a further 4-6 passages 
in the absence of ethidium bromide. The resulting cell line is referred to as 143B-ρ0. In order 
to determine that these ρ0 cells were devoid of mtDNA, total DNA (25 ng) from cells at 90% 
confluency in a single well was used as a template in real-time PCRs with AmpliTaq Gold 
DNA polymerase (Applied Biosystems) in an ABI 7900HT Fast Real-Time PCR instrument 
with primers and probes for the COXII gene in mitochondrial DNA and the nuclear gene for 
the amyloid precursor protein (53). A 6-carboxyfluorescein fluorophore and a 
tetramethylrhodamine quencher (Sigma Genosys) were attached to the 5′ and 3′ ends of the 
probes, respectively. The mtDNA copy number in HAP1-A12 cells was determined by the 
same method. 
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Opening of the PTP. The assays were based on the triggering of opening of the pore by three 
independent methods. In intact human cells pore opening was induced by thapsigargin (4), or 
ferutinin (5), and, in cells where the plasma membrane had been permeabilized with digitonin, 
by examination of the capacity of the mitochondria to retain Ca2+ introduced exogenously (54). 
Assays with thapsigargin and ferutinin. Mitochondrial membrane potential was monitored 
via the red fluorescence of tetramethylrhodamine methyl ester (TMRM; excitation and 
emission wavelengths 530 nm and 675 nm, respectively, with a 75 nm span). In order to follow 
pore opening, cells were loaded with the acetoxymethyl ester of calcein (calcein-AM), which 
diffuses into the cells and accumulates in cytosolic compartments, including mitochondria. 
Once inside cells, esterases remove the acetoxymethyl-group to liberate the green fluorescent 
calcein molecule, which does not cross the mitochondrial or plasma membranes appreciably 
during the assay. The fluorescence of cytosolic calcein (excitation and emission wavelengths, 
respectively of 475 and 560 nm, with a 35 nm span) is quenched by CoCl2, which cannot enter 
mitochondria and so the fluorescence of mitochondrial calcein is maintained. On triggering 
pore opening with Ca2+, this green fluorescence is quenched (55). In detail, the assay was 
performed as follows. Cells were grown to 20-30% confluence in 6-well plates. They were 
washed three times in modified HBSS buffer (1 mL) consisting of Hanks balanced salt solution 
(containing Ca2+ and Mg2+, with no phenol red, Thermo Fisher Scientific) plus 10 mM HEPES, 
pH 7.4, 2 mM GlutaMAX supplement (Invitrogen) and 1 mM sodium pyruvate, then kept at 
room temperature for 20 min in modified HBSS (1 mL) containing 1 µM calcein-AM (Life 
Technologies), 25 nM TMRM, and 8 mM CoCl2 (56). They were washed at 37
oC three times, 
each for 5 min, with modified HBSS containing 8 mM CoCl2 (1 mL), and incubated at 37
oC in 
modified HBSS (1 mL) containing 1 mM CoCl2, 20-40 µM thapsigargin or 25 µM ferutinin, 
for 60 min. When it was employed, the PTP inhibitor CsA (5 µM) was added 5 min before 
thapsigargin or ferutinin. The concentrations of thapsigargin and CsA were optimised for 
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HAP1 cells (Figs. S9 and S10). In the optimisation of CsA, cyclosporin H (CsH) was used to 
determine the extent of any possible off-target impact of cyclosporin compounds. CsH is 
significantly less effective at inhibiting cyclophilin D than CsA (57). The cells were washed 
twice with modified HBSS buffer (1 mL) containing 1 mM CoCl2 and finally with phosphate 
buffered saline (PBS; 2 mL) once. The cells were released from monolayers with trypsin and 
centrifuged (1300xg, 2 min), and the pellet was resuspended in PBS to a concentration of 1-
1.5 x 106 cells/mL. Nuclei were stained with Hoechst 33342 dye (10 µg/L, final concentration), 
and the cell suspension was incubated at 37oC for 15 min. The green and red fluorescence 
intensities of calcein and TMRM, respectively, in cells with or without treatment with 
thapsigargin or ferutinin were measured in each individual cell in samples of 5000 cells in a 
Nucleocounter NC3000 cell counting fluorescence microscope (ChemoMetec). The 
fluorescence intensities of individual cells were plotted on 2D scatter plots, one with the green 
and blue and the other with red and blue fluorescence intensities on the ordinate and abscissa, 
respectively. Orthogonal axes were drawn on the control so as to encompass all of the cells that 
formed a cluster based on their high fluorescence intensities into the upper two quadrants. The 
axes were placed automatically in the same positions on the experimental scatter plots, and the 
percentage fraction of cells in each quadrant was recorded by the instrument (see example in 
Fig. S11). The ratio of the positive percentage (the sums of “the percentage fractions” in the 
upper two quadrants) from experimentally perturbed and unperturbed control cells is the 
“relative ratio”. The averages of relative ratios from independent duplicate experiments were 
plotted on a bar chart. Standard deviations and statistical evaluations by student’s t-test were 
calculated with Excel software. 
Capacity of mitochondria to retain calcium. Wild-type HAP1 cells and HAP1-A12 cells 
were harvested by trypsinization, washed twice in Dulbecco’s phosphate buffered saline 
(DPBS, minus Ca2+and Mg2+). They were stained with trypan blue, and counted with a 
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Countess-II FL automated instrument (Thermo Fisher Scientific). Cells were suspended at a 
concentration of 20 x 106/ml in DPBS containing 2x cOmplete EDTA-free protease inhibitor 
cocktail (Roche), 20 μM EGTA and digitonin (Calbiochem) to 60 μg/ml, and left on ice for 10 
min. The resulting permeabilized cells were washed twice with DPBS containing 1x cOmplete 
inhibitors. Portions of cells (60 x 106) required for individual analyses were centrifuged and 
the cell pellets were kept on ice. Then a portion of the permeabilized cells was re-suspended at 
4oC in assay buffer (1 ml) containing 20 mM MOPS-Tris pH 7.2, 120 mM KCl, 10 mM NaCl, 
1 mM KH2PO4, 5 mM glutamate and 2.5 mM malate. The suspension was diluted 3-fold with 
assay buffer that had been warmed to 30 °C. Calcium green-5N (0.5 μM) and thapsigargin (1 
μM), to prevent Ca2+ uptake by the endoplasmic reticulum, were added. If it was intended to 
inhibit the opening of the pore with CsA (1 μM), it was added during this step. After 2 min, 
successive portions (10 μl) of 3 mM CaCl2 were added (giving a final concentration 10 μM) 
with stirring (500 rpm), and the fluorescence of the Calcium green-5N (excitation 505 nm, 
emission 531 nm) was monitored with a Shimadzu RF-5301PC spectrofluorophotometer. The 
CsA treated and untreated cells were always assessed in immediate succession in order to make 
them as comparable as possible. The mitochondrial calcium uniporter was inhibited by the 
addition of 0.5 μM Ru360 (Calbiochem) immediately after a single Ca2+ injection. 
Purification of ATP synthase. The procedure was carried out at 4oC. Cells were harvested in 
PBS containing EDTA-free protease inhibitors (Roche) and total cell protein was estimated by 
BCA assay (Thermo Scientific). Mitoplasts were prepared by re-suspension of cells to 5 
mg/mL in phosphate buffered saline containing 0.5 mg/mL digitonin, 1 mM dithiothreitol and 
protease inhibitors (58). After 15 min, they were centrifuged (10,500 x g, 5 min), washed in 
the same solution lacking digitonin, and extracted with buffer A, pH 8.0, containing 0.1 M Tris, 
0.15 M NaCl, glycerol (10% v/v), EDTA-free protease inhibitor, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (0.09 mg/mL), 1-palmitoyl-2-oleoyl-sn-glycero-3-
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phosphoethanolamine (0.03 mg/mL), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 
(0.03 mg/mL), 2 mM dithiothreitol and digitonin (9 g/g protein). The extract was centrifuged 
(10,500 x g, 10 min), and the supernatant filtered and stirred for 18 h with an ATP synthase 
immunocapture resin (Abcam, kit ab109715). The beads were washed in buffer B, differing 
from buffer A only in the concentration of Tris (20 mM), and the digitonin content (0.05%, 
w/v). Bound material was eluted in buffer, pH 2.5, containing 0.2 M glycine-HCl and digitonin 
(0.05%, w/v), and the eluate was neutralised with 1 M Tris. 
Mass spectrometric analysis. Stable isotopes were introduced into proteins by stable isotope 
labelling in cell culture (SILAC). Cells were grown for at least seven doublings in SILAC 
medium (59) supplemented with proline (200 mg/L), dialysed fetal bovine serum (10%, v/v), 
penicillin (100 U/mL), streptomycin (100 g/mL) and either light (R0K0) or heavy (R10K8) 
isotopes of L-arginine (0.398 mM) and L-lysine (0.798 mM). Each analysis was based on two 
SILAC experiments one in which the HAP1-A12 cells, or the 143B ρ0 cells, were labelled in 
heavy medium and the HAP1 wild-type or the 143B ρ+ cells in light media, and the second 
vice versa. Each sample for mass spectrometry consisted of the mitoplast material or ATP 
synthase purified as above from a 1:1 mixture (based on the protein content) of light and heavy 
labelled cells (HAP1-A12 and HAP1 wild-type; 143B ρ0 and 143B ρ+). Samples were reduced, 
alkylated and fractionated by SDS-PAGE, and the bands were detected with Coomassie blue 
dye (60). In-gel tryptic digests (61) of gel slices covering the entire gel track were analysed by 
LC-MSMS on a Proxeon EASY-nLC system coupled directly to a LTQ OrbiTrap XL or a Q-
Exactive Orbitrap mass spectrometer (ThermoFisher Scientific). Data were processed with 
MaxQuant version 1.5.0.12 and the integrated Andromeda search engine (62, 63), using a 
Swiss-Prot human protein database (version July 2016) modified to include mature forms of 
IF1 with N-terminal residues Phe-25, Gly-26 and Ser-27 (64, 65), and managed further with 
Perseus (66). Protein ratios for the various forms of IF1 were calculated from unique peptides 
 21 
from the import sequence or the N-termini of mature forms, performed manually from the 
output of the MaxQuant evidence file. The basis of the quantitative experiments using SILAC 
has been explained before (67). 
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Figures 
 
Fig. 1. Expression of the c-subunit of human ATP synthase in HAP1 clonal cells following 
attempted disruption of genes ATP5G1, ATP5G2 and ATP5G3. Total cell proteins from each 
clone were fractionated by SDS-PAGE, and the β- and c-subunits of the ATP synthase and 
Tom20 were detected with antibodies. The results for 14 of the 24 clones that were examined 
are shown. The A12 clone lacking subunit c is boxed. The signals from the β-subunit and 
Tom20 are weaker than in other tracks because the HAP1-A12 clone grows slower, and thus 
the analysed colony contains fewer cells. 
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Fig. 2. Characteristics of HAP1-A12 cells. In A and C, ●, HAP1 wild-type cells; ■, HAP1-
A12 cells. A, growth rates of HAP1 cells. About 40,000 cells were seeded into individual wells 
of a 6-well plate, and their confluence was monitored over 96 h. The data points are the mean 
values SD (n=3); B, the relative copy numbers of mtDNA in HAP1 cells. Regions of the genes 
for COX II and the amyloid precursor protein (APP) were amplified and quantitated as indices 
of mitochondrial and nuclear DNA, respectively. All data are the mean values SDs (n=4); C, 
cellular oxygen consumption rates (OCR) before and after sequential additions of 2-
deoxyglucose (2-DG), oligomycin (Oligo), carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), and a mixture of rotenone and antimycin A 
(Rot/AA), at the times indicated. Data represent the mean ±SEM (n=8 or 9 wells). D and E, 
TMRM fluorescence measurements with permeabilized wild-type HAP1 and HAP1-A12 cells, 
respectively, normalized to zero after the addition of succinate and to 1 following FCCP 
treatment; 5 mM glutamate and 2.5 mM malate (G-M), 0.1 mM ADP; 1 μM oligomycin 
(Oligo), 1 μM rotenone (Rot), 10 mM succinate (Suc), and 1 μM FCCP were added as 
indicated. 
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Fig. 3. The opening of the PTP in HAP1 cells. A, wild-type cells; B, HAP1-A12 cells. The 
cells were stained with both calcein and TMRM, and then incubated for 1 h in the presence of 
either 40 M thapsigargin (TG) or 25 M ferutinin (FT). Duplicate samples were incubated 
first in the presence of 5 M cyclosporin A (CsA), and then treated with either thapsigargin or 
ferutinin. Grey and white columns correspond to the retention ratios for calcein and TMRM, 
respectively, compared with cells treated with the vehicle DMSO only. All data are mean 
values SDs (n=4). 
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Fig. 4. Calcium induced opening of the PTP in permeabilized HAP1 cells. A-C, wild-type cells; 
D-F, HAP1-A12 cells; G-H, HAP1-ΔPPIF cells. The calcium retention capacity of 
mitochondria in digitonin permeabilized cells (20 x 106 cells/ml) was examined in response to 
pulses of 10 μM CaCl2. Extra-mitochondrial Ca2+ was measured with Calcium green-5N 
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fluorescence (a.u., arbitrary unit). A, D and G, and B, E and H, respectively, the calcium 
retention capacity in the absence and presence of CsA (1 μM). C and F, effect on wild-type and 
HAP1-A12 cells, respectively, of inhibition of the mitochondrial calcium uniporter with Ru360 
(0.5 μM) added immediately after a single pulse of Ca2+. 
 
Fig 5. Effects of the deletion of the c-subunit of human ATP synthase in HAP1-A12 cells, and 
of the removal of ATP6 and ATP8 in ρ0 cells. Part A, impact of removal of c-subunits on the 
subunit composition of the vestigial ATP synthase complex. The complex was purified from 
mitoplasts derived from wild-type (WT) HAP1 and HAP1-A12 cells and analyzed by SDS-
PAGE. Part B, relative abundance of subunits of ATP synthase and one of the mature forms of 
the ATPase inhibitor protein, IF1-M1 (see Fig. S6). The complex and residual complex were 
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purified from a 1:1 mixture of SILAC-labelled wild-type HAP1 cells and HAP1-A12 cells, 
respectively, and tryptic peptides were analyzed by quantitative mass spectrometry. The 
experiment was performed twice with reciprocal protein labelling. The bars represent median 
values of both relative abundance ratios determined for proteins identified in the 
complementary SILAC labelling experiments. Error bars show the range of the two values. 
Parts C and D, ATP synthase and the vestigial complex purified by immunocapture from 
digitonin extracts of mitoplasts from 143B ρ+ and ρ0 cells and analyzed as in A and B 
respectively. The proteins in A and C were stained with silver. Subunits were identified by 
mass spectrometric analysis of tryptic digests of bands from a duplicate gel stained with 
Coomassie blue dye. The histograms are derived from the data in Fig. S5 and Tables S5-S8. 
Isoforms 1 and 2 of the f-subunit (f-1 and f-2; see Fig. S6) were identified in human cells. 
 
Fig. 6. Oligomeric state of ATP synthase in HAP1 and 143B ρ+ cells, and of vestigial ATP 
synthase complexes in HAP1-A12 and 143B ρ0 cells. Mitoplasts were extracted with various 
concentrations of digitonin/protein (w/w) indicated above each lane. The ATP synthase and 
vestigial complexes were purified by immunoaffinity, and analysed by BN-PAGE and detected 
by Western blotting with an antibody against the β-subunit. Parts A and B, analysis of, 
respectively, HAP1 wild-type (WT) and HAP1-A12 cells, and 143B ρ+ and ρ0 cells. In A, 
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citrate synthase (CS) was employed as a loading control. o, oligomers; d, dimers; m, 
monomers; m*, other complexes of unknown oligomeric state. 
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Fig. S1. Structures of the human ATP5G1, ATP5G2 and ATP5G3 genes and the sequences of 
the three encoded precursors of the c-subunit of the ATP synthase. A, the genes; exons I-V and 
introns A-D are represented by solid boxes and continuous lines, respectively. Their sizes are 
given in base pairs. B, the sequences of the encoded proteins. Only the import sequences are 
surrounded by blue. Asterisks denote identities. 
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Fig. S2. Transcription of the human genes ATP5G1, ATP5G2 and ATP5G3 in HAP1 cells. 
The values are normalized to endogenous β-actin and displayed relative to the ATP5G3 
transcript, and the error bars show the standard deviations. 
Table S1. Target site for gRNA molecules employed in the disruption of the human 
ATP5G1, ATP5G2 and ATP5G3 genes. 
gRNA Target site 
ATP5G1-1 ACAGCAACTTCCCACTCCAG 
ATP5G1-2 TGTTTGGCAGCTTGATCATT 
ATP5G2-1 GCGCCATTTCAAGGGACATC 
ATP5G2-2 CTGGGATTGGAACTGTGTTT 
ATP5G3-1 AAGGGAGTTTCAGACCAGTG 
ATP5G3-2 GCTGCCAAATTTATTGGTGC 
 
Table S2. Primers employed in the amplification by PCR of the exon targeted by gRNAs in 
the human ATP5G1, ATP5G2 and ATP5G3 genes. 
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Primer Sequence 
ATP5G1-Forward GCAGTTTGCCAACAGTTTCAGAG 
ATP5G1-Reverse GATGAAATCAACCTGAAGGCTCCTG 
ATP5G2-Forward AGGCAAATGCTTCTGAGGCT 
ATP5G2-Reverse GTGCCAGTTTTCCCAGGAGT 
ATP5G3-Forward ATTTGTCTCTTTACACTCAGCTACA 
ATP5G3-Reverse GCTAAGTTTCCAACTACTGCAAGC 
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Fig. S3. Deletion of sequences in HAP1 wild-type cells to produce the HAP1-A12 strain. In 
A-C are shown exons IV of the human ATP5G1 and ATP5G2, and exon III of the ATP5G3 
gene, respectively, encoding the subunit c of human ATP synthase. In the upper part of each 
panel, the sequences of the targeted exon of each gene in the parental or wild-type (WT) cells 
are aligned with the corresponding deleted sequence in the HAP1-A12 cells. Carets indicate 
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the PAM (protospacer adjacent motif) sequences for each guide RNA, and solid bars the guide 
RNA target sequences. In the lower part of A-C, the impacts of the deletions on the sequences 
of the import precursors of the c-subunit are shown. The start of the mature protein is indicated. 
Amino acid changes introduced by the process of deletion are indicated by asterisks. Dashed 
lines indicate deletions in DNA and protein sequences. 
 
Fig. S4. Comparison of the efficiency of staining of HAP1 wild-type cells and HAP1-A12 cells 
by calcein and TMRM. Grey and white histograms correspond to cells stained with calcein 
and/or TMRM, respectively. The percentage of fluorescent cells was determined with a 
Nucleocounter 3000. All data are the mean values  SDs (n=4). 
Table S3. Number of calcium pulses recorded in permeabilized wild-type HAP1 cells. 
The values in the first row refer to Fig. 4A and 4B. Rows 2-9 correspond to replicate 
experiments. 
No CsA With CsA  Ratio 
7 20 2.86 
6 26 4.33 
5 13 2.6 
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11 25 2.27 
7 21 3.0 
11 30 2.86 
7 21 3.0 
7 21 3.0 
5 11 2.2 
Av. 7.3 Av. 20.9 Av. 2.89 
SD. 2.2 SD. 6.0 SD. 0.62 
 
Table S4. Number of calcium pulses recorded in permeabilized HAP1-A12 cells. 
The values in the first row refer to Fig. 4D and 4E. Rows 2-4 correspond to replicate 
experiments. 
No CsA With CsA  Ratio 
8 21 2.63 
14 40 2.86 
9 18 2.0 
7 17 2.43 
Av. 9.5 Av. 24.0 Av. 2.48 
SD. 3.1 SD. 10.8 SD. 0.36 
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Fig. S5. Effects on protein relative abundance of the deletion of the c-subunit of human ATP 
synthase in HAP1 cells, and of the removal of ATP6 and ATP8 in 143B ρ0 cells. Relative 
quantitative mass spectrometry analyses of proteins in mitoplasts (parts A and C) and purified 
ATP synthase (parts B and D) prepared from a 1:1 mixture of cells that were differentially 
SILAC-labelled. Panels A and B show the analyses of wild-type HAP1 cells combined with 
HAP1-A12 cells devoid of the ATP synthase c-subunit, and C and D the data from wild-type 
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143B ρ+ cells and ρ0 cells lacking mitochondrial DNA. The experiments were performed twice, 
using reciprocal SILAC labelling orientations. For all the scatter plots each data point 
corresponds to the relative abundance ratio of an identified protein from the two 
complementary labelling experiments. ●, ATP synthase subunits and the precursor (P), or the 
M1 mature form of IF1; ●, all other identified proteins. Protein ratios and peptide evidence for 
IF1 are listed in Tables S5 to S12. 
 
Fig. S6. Sequences of the precursor and mature forms of the inhibitor protein IF1 and isoforms 
of subunit f of the human mitochondrial ATP synthase. The asterisks denote that the initiator 
methionine residue has been removed, and residue alanine-2 has been Nα-acetylated. A, 
residues 1-60 of the initial precursor form of IF1 (top line) and formation of IF1-P, and below 
the observed mature forms IF1-M1 and IF1-M2; B, complete sequences of isoforms f-1 and f-
2. They arise by an alternative splicing mechanism, and differ in the region denoted by shading 
and dashes. Both isoforms were observed in mass spectrometric analyses. Subunit f lacks a 
processed N-terminal mitochondrial import sequence. 
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Fig. S7. Presence of the PTP in human 143B cells. A, and B, + and 0 cells. Retention ratios 
in 143B cells for calcein (grey) and TMRM (white). The cells were treated with 20 M 
thapsigargin (TG) or 25 M ferutinin (FT) for 1 h, respectively, with or without CsA (5 M). 
TG activated cells were treated with CsA before staining whereas the FT cells were stained 
with calcein and TMRM, and then treated with CsA. All ratios were normalized to the untreated 
143B cells (loaded with DMSO vehicle). The data represent means  SDs (TG, n=4; FT, n=2). 
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Fig. S8. Structure of the c8-ring from bovine ATP synthase. As the sequences of the bovine 
and human c-subunits are the same, the structures of their c8-rings are identical. A, cross-
section of the ring showing concentric annuli of N- and C-terminal transmembrane α-helices; 
B, external view of the surface of the intact ring (inner and outer yellow and grey rings, 
respectively); C, internal view of the surface of half of the ring (four c-subunits). In the inner 
ring, yellow, pink, red and blue regions denote hydrophobic, hydrophilic, basic and acidic 
residues, respectively; D, view of the region of contact between the c8-ring (below) and foot of 
the central stalk, in the enzyme’s rotor. Blue, green and magenta areas are parts of the γ-, δ- 
and ε-subunits. The c8-ring is grey. The red box indicates a small crevice in the model at 3.5 Å 
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resolution leading to the central cavity. In reality, the crevice is probably occupied by the side 
chains of amino acids, which were truncated at the β-carbon atom in the model. 
 
Fig. S9. Optimisation of thapsigargin concentrations on the opening of the PTP in wild-type 
HAP1 cells. A, the cells were stained with both calcein and TMRM, then incubated for 1 h 
with various concentrations of thapsigargin. Grey and white columns represent the retention 
ratios for calcein and TMRM fluorescence signals, respectively, relative to untreated cells. B, 
HAP1 cell viability after treatment with thapsigargin for 1 h was assessed by both trypan blue 
and propidium iodide staining, with a Countess-II FL automated cell counter (Thermo Fisher 
Scientific) or a NC3000 advanced image cytometer (ChemoMetec), respectively. The values 
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are expressed relative to untreated HAP1 cells.   
 
Fig. S10. Cyclosporin A concentration dependent inhibition of the PTP in wild-type HAP1 
cells. Cells were stained with both calcein and TMRM, then pre-incubated with different 
concentrations of CsA or CsH for 5 min, and then treated for 1 h with 40 μM thapsigargin (A) 
or 25 μM ferutinin (B). The fluorescence retention ratio for calcein and TMRM was 
determined, relative to untreated cells. Grey and white columns difference values (CsA minus 
CsH) for calcein and TMRM fluorescence signals, respectively. 
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Fig. S11. An example of scatter plots used in the assay of the PTP. HAP1-A12 (A12) and 
HAP1 wild-type (WT) cells were stained with both calcein and TMRM. Then both sets of cells 
were incubated for 1 h in the presence of 25 µM ferutinin (FT) or DMSO vehicle, respectively. 
Green and red fluorescence intensities of calcein and TMRM, respectively, of samples of 5000 
cells with or without treatment with ferutinin were measured in a Nucleocounter NC3000 cell 
counting fluorescence microscope (ChemoMetec). Then, orthogonal axes were drawn 
manually on the 2D scatter plots for the WT cells and then used as the master template for the 
scatter plots for the HAP1-A12 cells. The relative calcein retention ratio was calculated as the 
ratio of HAP1-A12 positive percentages (the sum of the two percentages in the upper quadrants 
for A12: 7+3%=10%) and the positive percentages for wild-type cells (WT) (the sum of the 
two percentages in the corresponding upper quadrants: 90+2%=92%). The values of intensities 
on both axes should be multiplied by 103. 
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Supplementary Table S5. Proteins identified in SILAC experiments comparing 
immunopurifed ATP synthase from wild-type and HAP1-A12 cells. 
Supplementary Table S6. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing ATP synthase from wild-type and HAP1-A12 cells. 
Supplementary Table S7. Proteins identified in SILAC experiments comparing 
immunopurified ATP synthase from wild-type and 143B ρ0 cells. 
Supplementary Table S8. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing ATP synthase from wild-type and ρ0 143B cells. 
Supplementary Table S9. Proteins identified in SILAC experiments comparing mitoplasts 
from wild-type and HAP1-A12 cells. 
Supplementary Table S10. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing mitoplasts from wild-type and HAP1-A12 cells. 
Supplementary Table S11. Proteins identified in SILAC experiments comparing mitoplast 
material from wild-type and 143B ρ0 cells. 
Supplementary Table S12. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing mitoplasts from wild-type and 143B ρ0 cells. 
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Materials and Methods 
Cell culture. Near-haploid human HAP1 cells (Horizon Discovery) and derived cell lines 
HAP1-A12 and HAP1-ΔPPIF (HZGHC004185c012), where the gene encoding cyclophilin D 
had been disrupted (Horizon Discovery) were grown at 37oC in the presence of 5% carbon 
dioxide in Iscove’s modified Dulbecco’s medium (IMDM) plus 10% (v/v) fetal bovine serum 
(FBS). Human osteosarcoma 143B cells (ATCC CRL-8303) were grown under similar 
conditions in Dulbecco’s Modified Eagle’s Medium (DMEM) containing glucose (4.5 g/L) and 
pyruvate (110 mg/L), FBS (10%, v/v), penicillin (100 units/mL) and streptomycin (0.1 
mg/mL). The medium for cultivation of 143B ρ0 cells contained additionally uridine (100 
μg/mL). To determine cell growth rates, initially, 4 x 104 wild-type HAP1 or HAP1-A12 cells 
were plated in triplicate, and estimates of confluence were made with an IncuCyte HD and 
2011A Rev2 software (Essen Bioscience) at 8 h intervals over 4 days. 
The oxygen consumption rate (OCR) of cells was determined with a Seahorse XFe24 
instrument (Agilent Technologies). These measurements were made with cells in XF assay 
medium plus 2 mM glucose and 1 mM pyruvate. 2-Deoxyglucose, oligomycin, carbonyl 
cyanide-4-(trifluoromethoxy)-phenylhydrazone, and a mixture of rotenone and antimycin A, 
were introduced successively at final concentrations of 20 mM, 1 μM, 0.5 μM and 0.6 μM 
each, respectively. 
 The generation of a mitochondrial membrane potential in wild-type HAP1 cells and 
HAP1-A12 cells was monitored in digitonin permeabilized cells (see below) by following the 
fluorescent signal from unbound TMRM (excitation 550 nm/emission 575 nm) with a 
Shimadzu RF-5301PC spectrofluorophotometer. Permeabilized cells were used at a 
concentration of 10 x 106/ml in 2 ml of a solution containing 120 mM KCl, 10 mM NaCl, 1 
mM KH2PO4, 20 mM MOPS-Tris pH 7.2, and 80 nM TMRM. Fluorescence changes were 
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measured at 30°C with stirring (500 rpm), following the addition of mitochondrial respiratory 
substrates (5 mM glutamate, 2.5 mM malate, 0.1 mM ADP or 10 mM succinate) and inhibitors 
(1 μM oligomycin, 1 μM rotenone, 1 μM antimycin-A or 1 μM carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone) at the times indicated on the traces. 
Transcription of the ATP5G1, ATP5G2 and ATP5G3 genes. The levels of transcripts for 
the c-subunit from ATP5G1, ATP5G2 and ATP5G3 in HAP1 cells relative to β-actin were 
estimated by qPCR in an ABI 7900HT Fast Real-Time PCR instrument with specific TaqMan 
gene expression assays and reagents (Thermo Fisher Scientific). 
Disruption of ATP5G1, ATP5G2 and ATP5G3. Three pairs of specific guide RNA 
molecules (gRNAs) directed against exon IV of genes ATP5G1 and ATP5G2 and exon III of 
ATP5G3 were identified and optimised with a design tool for CRISPR (clustered regularly 
interspaced short palindromic repeats; see crispr.mit.edu), synthesised and cloned into the BbsI 
site of plasmid pSpCas9(BB)-2A-GFP (1) (Addgene). This plasmid encodes the CRISPR 
associated protein 9 (Cas9) from Streptococcus pyrogenes separated from the coding sequence 
for the green fluorescent protein (GFP) by a 2A sequence. This arrangement leads to GFP being 
transcribed from the same gene as Cas9, but translated separately from it, allowing cells into 
which Cas9 has been introduced successfully to be separated and enriched in a fluorescence 
activated cell sorter. It also expresses the sgRNA consisting of the gRNA fused to a scaffold 
under the control of the human U6 promoter. The six plasmids (each 0.5 µg) were co-
transfected in the presence of lipofectamine 3000 (Thermo Fisher Scientific) into 40-60% 
confluent HAP1 cells grown in a single well of a six-well plate. Two days later, cells were 
released with trypsin, and resuspended in IMDM containing 10% (v/v) FBS to a density of 1-
2 x 106 cells/mL. Green fluorescent cells were separated into single cells in 96 well plates with 
a High Speed Influx Cell Sorter (BD Biosciences). They were grown at 37oC in the presence 
of 5% carbon dioxide for 2-3 weeks in IMDM plus 10% FBS until single colonies had formed 
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in each well. Then they were transferred into 24-well plates, expanded in triplicate, and stored 
at -80oC in IMDM containing 50% (v/v) FBS and 10% (v/v) dimethylsulfoxide.  
Cells in a single well were disrupted for 30 min at room temperature with buffer (100 
μL) containing 10 mM Tris.Cl, pH 7.4, 0.2% (w/v) SDS, 1x cOmplete EDTA-free proteinase 
inhibitor cocktail (Roche) and 0.5 units of benzonase (Merck Millipore). Loading buffer (five 
times normal concentration) was diluted to normal concentration with the sample, and a portion 
(10-15 μL) was fractionated on a 10-20% acrylamide gradient protein mini-gel (Thermo Fisher 
Scientific). Proteins were transferred electrophoretically onto nitrocellulose membranes, and 
exposed to rabbit antibodies against subunit c (Abcam), and, as loading controls, against 
Tom20 and the β-subunit of ATP synthase (both Santa Cruz Biotechnology). 
The deleted regions of genes were characterized by PCR and DNA sequencing (Source 
Bioscience). Cells in a single well of a 24-well plate were resuspended in a solution (200 μL) 
containing 0.2% (w/v) SDS, 75 mM NaCl, 20 mM EDTA and proteinase K (0.4 mg/mL), and 
the suspension was incubated at 50oC for 2 h. DNA was precipitated with isopropanol, washed 
with 70% (v/v) ethanol, dried, and redissolved in buffer (100 μL) containing 10 mM Tris.Cl, 
pH 8.0. The regions containing exons IV of ATP5G1, ATP5G2 and exon III of ATP5G3 were 
amplified by PCR, and the product sizes analysed by agarose gel electrophoresis. For clone 
A12, the appropriate PCR fragments were cloned with a TOPO TA Cloning Kit (Thermo Fisher 
Scientific), and their DNA sequences were determined. 
Generation of ρ0 cells. 143B cells were cultured for ca. 8 weeks as above, but in the presence 
of ethidium bromide (100 μg/mL) and uridine (100 μg/mL), and then for a further 4-6 passages 
in the absence of ethidium bromide. The resulting cell line is referred to as 143B-ρ0. In order 
to determine that these ρ0 cells were devoid of mtDNA, total DNA (25 ng) from cells at 90% 
confluency in a single well was used as a template in real-time PCRs with AmpliTaq Gold 
DNA polymerase (Applied Biosystems) in an ABI 7900HT Fast Real-Time PCR instrument 
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with primers and probes for the COXII gene in mitochondrial DNA and the nuclear gene for 
the amyloid precursor protein (2). A 6-carboxyfluorescein fluorophore and a 
tetramethylrhodamine quencher (Sigma Genosys) were attached to the 5′ and 3′ ends of the 
probes, respectively. The mtDNA copy number in HAP1-A12 cells was determined by the 
same method. 
Opening of the PTP. The assays were based on the triggering of opening of the pore by three 
independent methods. In intact human cells pore opening was induced by thapsigargin (3), or 
ferutinin (4), and, in cells where the plasma membrane had been permeabilized with digitonin, 
by examination of the capacity of the mitochondria to retain Ca2+ introduced exogenously (5). 
Assays with thapsigargin and ferutinin. Mitochondrial membrane potential was monitored 
via the red fluorescence of tetramethylrhodamine methyl ester (TMRM; excitation and 
emission wavelengths 530 nm and 675 nm, respectively, with a 75 nm span). In order to follow 
pore opening, cells were loaded with the acetoxymethyl ester of calcein (calcein-AM), which 
diffuses into the cells and accumulates in cytosolic compartments, including mitochondria. 
Once inside cells, esterases remove the acetoxymethyl-group to liberate the green fluorescent 
calcein molecule, which does not cross the mitochondrial or plasma membranes appreciably 
during the assay. The fluorescence of cytosolic calcein (excitation and emission wavelengths, 
respectively of 475 and 560 nm, with a 35 nm span) is quenched by CoCl2, which cannot enter 
mitochondria and so the fluorescence of mitochondrial calcein is maintained. On triggering 
pore opening with Ca2+, this green fluorescence is quenched (6). In detail, the assay was 
performed as follows. Cells were grown to 20-30% confluence in 6-well plates. They were 
washed three times in modified HBSS buffer (1 mL) consisting of Hanks balanced salt solution 
(containing Ca2+ and Mg2+, with no phenol red, Thermo Fisher Scientific) plus 10 mM HEPES, 
pH 7.4, 2 mM GlutaMAX supplement (Invitrogen) and 1 mM sodium pyruvate, then kept at 
room temperature for 20 min in modified HBSS (1 mL) containing 1 µM calcein-AM (Life 
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Technologies), 25 nM TMRM, and 8 mM CoCl2 (7). They were washed at 37
oC three times, 
each for 5 min, with modified HBSS containing 8 mM CoCl2 (1 mL), and incubated at 37
oC in 
modified HBSS (1 mL) containing 1 mM CoCl2, 20-40 µM thapsigargin or 25 µM ferutinin, 
for 60 min. When it was employed, the PTP inhibitor CsA (5 µM) was added 5 min before 
thapsigargin or ferutinin. The concentrations of thapsigargin and CsA were optimised for 
HAP1 cells (Figs. S10 and S11). In the optimisation of CsA, cyclosporin H (CsH) was used to 
determine the extent of any possible off-target impact of cyclosporin compounds. CsH is 
significantly less effective at inhibiting cyclophilin D than CsA (8). The cells were washed 
twice with modified HBSS buffer (1 mL) containing 1 mM CoCl2 and finally with phosphate 
buffered saline (PBS; 2 mL) once. The cells were released from monolayers with trypsin and 
centrifuged (1300xg, 2 min), and the pellet was resuspended in PBS to a concentration of 1-
1.5 x 106 cells/mL. Nuclei were stained with Hoechst 33342 dye (10 µg/L, final concentration), 
and the cell suspension was incubated at 37oC for 15 min. The green and red fluorescence 
intensities of calcein and TMRM, respectively, in cells with or without treatment with 
thapsigargin or ferutinin were measured in each individual cell in samples of 5000 cells in a 
Nucleocounter NC3000 cell counting fluorescence microscope (ChemoMetec). The 
fluorescence intensities of individual cells were plotted on 2D scatter plots, one with the green 
and blue and the other with red and blue fluorescence intensities on the ordinate and abscissa, 
respectively. Orthogonal axes were drawn on the control so as to encompass all of the cells that 
formed a cluster based on their high fluorescence intensities into the upper two quadrants. The 
axes were placed automatically in the same positions on the experimental scatter plots, and the 
percentage fraction of cells in each quadrant was recorded by the instrument (see example in 
Fig. S12). The ratio of the positive percentage (the sums of “the percentage fractions” in the 
upper two quadrants) from experimentally perturbed and unperturbed control cells is the 
“relative ratio”. The averages of relative ratios from independent duplicate experiments were 
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plotted on a bar chart. Standard deviations and statistical evaluations by student’s t-test were 
calculated with Excel software. 
Capacity of mitochondria to retain calcium. Wild-type HAP1 cells and HAP1-A12 cells 
were harvested by trypsinization, washed twice in Dulbecco’s phosphate buffered saline 
(DPBS, minus Ca2+and Mg2+). They were stained with trypan blue, and counted with a 
Countess-II FL automated instrument (Thermo Fisher Scientific). Cells were suspended at a 
concentration of 20 x 106/ml in DPBS containing 2x cOmplete EDTA-free protease inhibitor 
cocktail (Roche), 20 μM EGTA and digitonin (Calbiochem) to 60 μg/ml, and left on ice for 10 
min. The resulting permeabilized cells were washed twice with DPBS containing 1x cOmplete 
inhibitors. Portions of cells (60 x 106) required for individual analyses were centrifuged and 
the cell pellets were kept on ice. Then a portion of the permeabilized cells was re-suspended at 
4oC in assay buffer (1 ml) containing 20 mM MOPS-Tris pH 7.2, 120 mM KCl, 10 mM NaCl, 
1 mM KH2PO4, 5 mM glutamate and 2.5 mM malate. The suspension was diluted 3-fold with 
assay buffer that had been warmed to 30 °C. Calcium green-5N (0.5 μM) and thapsigargin (1 
μM), to prevent Ca2+ uptake by the endoplasmic reticulum, were added. If it was intended to 
inhibit the opening of the pore with CsA (1 μM), it was added during this step. After 2 min, 
successive portions (10 μl) of 3 mM CaCl2 were added (giving a final concentration 10 μM) 
with stirring (500 rpm), and the fluorescence of the Calcium green-5N (excitation 505 nm, 
emission 531 nm) was monitored with a Shimadzu RF-5301PC spectrofluorophotometer. The 
CsA treated and untreated cells were always assessed in immediate succession in order to make 
them as comparable as possible. The mitochondrial calcium uniporter was inhibited by the 
addition of 0.5 μM Ru360 (Calbiochem) immediately after a single Ca2+ injection. 
Purification of ATP synthase. The procedure was carried out at 4oC. Cells were harvested in 
PBS containing EDTA-free protease inhibitors (Roche) and total cell protein was estimated by 
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BCA assay (Thermo Scientific). Mitoplasts were prepared by re-suspension of cells to 5 
mg/mL in phosphate buffered saline containing 0.5 mg/mL digitonin, 1 mM dithiothreitol and 
protease inhibitors (9). After 15 min, they were centrifuged (10,500 x g, 5 min), washed in the 
same solution lacking digitonin, and extracted with buffer A, pH 8.0, containing 0.1 M Tris, 
0.15 M NaCl, glycerol (10% v/v), EDTA-free protease inhibitor, 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (0.09 mg/mL), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (0.03 mg/mL), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol 
(0.03 mg/mL), 2 mM dithiothreitol and digitonin (9 g/g protein). The extract was centrifuged 
(10,500 x g, 10 min), and the supernatant filtered and stirred for 18 h with an ATP synthase 
immunocapture resin (Abcam, kit ab109715). The beads were washed in buffer B, differing 
from buffer A only in the concentration of Tris (20 mM), and the digitonin content (0.05%, 
w/v). Bound material was eluted in buffer, pH 2.5, containing 0.2 M glycine-HCl and digitonin 
(0.05%, w/v), and the eluate was neutralised with 1 M Tris. 
Mass spectrometric analysis. Stable isotopes were introduced into proteins by stable isotope 
labelling in cell culture (SILAC). Cells were grown for at least seven doublings in SILAC 
medium (10) supplemented with proline (200 mg/L), dialysed fetal bovine serum (10%, v/v), 
penicillin (100 U/mL), streptomycin (100 g/mL) and either light (R0K0) or heavy (R10K8) 
isotopes of L-arginine (0.398 mM) and L-lysine (0.798 mM). Each analysis was based on two 
SILAC experiments one in which the HAP1-A12 cells, or the 143B ρ0 cells, were labelled in 
heavy medium and the HAP1 wild-type or the 143B ρ+ cells in light media, and the second 
vice versa. Each sample for mass spectrometry consisted of the mitoplast material or ATP 
synthase purified as above from a 1:1 mixture (based on the protein content) of light and heavy 
labelled cells (HAP1-A12 and HAP1 wild-type; 143B ρ0 and 143B ρ+). Samples were reduced, 
alkylated and fractionated by SDS-PAGE, and the bands were detected with Coomassie blue 
dye (11). In-gel tryptic digests (12) of gel slices covering the entire gel track were analysed by 
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LC-MSMS on a Proxeon EASY-nLC system coupled directly to a LTQ OrbiTrap XL or a Q-
Exactive Orbitrap mass spectrometer (ThermoFisher Scientific). Data were processed with 
MaxQuant version 1.5.0.12 and the integrated Andromeda search engine (13, 14), using a 
Swiss-Prot human protein database (version July 2016) modified to include mature forms of 
IF1 with N-terminal residues Phe-25, Gly-26 and Ser-27 (15, 16), and managed further with 
Perseus (17). Protein ratios for the various forms of IF1 were calculated from unique peptides 
from the import sequence or the N-termini of mature forms, performed manually from the 
output of the MaxQuant evidence file. The basis of the quantitative experiments using SILAC 
has been explained before (18). 
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Fig. S1. Structures of the human ATP5G1, ATP5G2 and ATP5G3 genes and the sequences of 
the three encoded precursors of the c-subunit of the ATP synthase. A, the genes; exons I-V and 
introns A-D are represented by solid boxes and continuous lines, respectively. Their sizes are 
given in base pairs. B, the sequences of the encoded proteins. Only the import sequences are 
surrounded by blue. Asterisks denote identities. 
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Fig. S2. Transcription of the human genes ATP5G1, ATP5G2 and ATP5G3 in HAP1 cells. 
The values are normalized to endogenous β-actin and displayed relative to the ATP5G3 
transcript, and the error bars show the standard deviations. 
 
 
 
Table S1. Target site for gRNA molecules employed in the disruption of the human 
ATP5G1, ATP5G2 and ATP5G3 genes. 
gRNA Target site 
ATP5G1-1 ACAGCAACTTCCCACTCCAG 
ATP5G1-2 TGTTTGGCAGCTTGATCATT 
ATP5G2-1 GCGCCATTTCAAGGGACATC 
ATP5G2-2 CTGGGATTGGAACTGTGTTT 
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ATP5G3-1 AAGGGAGTTTCAGACCAGTG 
ATP5G3-2 GCTGCCAAATTTATTGGTGC 
 
Table S2. Primers employed in the amplification by PCR of the exon targeted by gRNAs in 
the human ATP5G1, ATP5G2 and ATP5G3 genes. 
Primer Sequence 
ATP5G1-Forward GCAGTTTGCCAACAGTTTCAGAG 
ATP5G1-Reverse GATGAAATCAACCTGAAGGCTCCTG 
ATP5G2-Forward AGGCAAATGCTTCTGAGGCT 
ATP5G2-Reverse GTGCCAGTTTTCCCAGGAGT 
ATP5G3-Forward ATTTGTCTCTTTACACTCAGCTACA 
ATP5G3-Reverse GCTAAGTTTCCAACTACTGCAAGC 
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Fig. S3. Deletion of sequences in HAP1 wild-type cells to produce the HAP1-A12 strain. In 
A-C are shown exons IV of the human ATP5G1 and ATP5G2, and exon III of the ATP5G3 
gene, respectively, encoding the subunit c of human ATP synthase. In the upper part of each 
panel, the sequences of the targeted exon of each gene in the parental or wild-type (WT) cells 
are aligned with the corresponding deleted sequence in the HAP1-A12 cells. Carets indicate 
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the PAM (protospacer adjacent motif) sequences for each guide RNA, and solid bars the guide 
RNA target sequences. In the lower part of A-C, the impacts of the deletions on the sequences 
of the import precursors of the c-subunit are shown. The start of the mature protein is indicated. 
Amino acid changes introduced by the process of deletion are indicated by asterisks. Dashed 
lines indicate deletions in DNA and protein sequences. 
 
Fig. S4. Characteristics of HAP1-A12 cells. In A and C, ●, HAP1 wild-type cells; ■, HAP1-
A12 cells. A, growth rates of HAP1 cells. About 40,000 cells were seeded into individual wells 
of a 6-well plate, and their confluence was monitored over 96 h. The data points are the mean 
values SD (n=3); B, the relative copy numbers of mtDNA in HAP1 cells. Regions of the genes 
for COX II and the amyloid precursor protein (APP) were amplified and quantitated as indices 
of mitochondrial and nuclear DNA, respectively. All data are the mean values SDs (n=4); C, 
cellular oxygen consumption rates (OCR) before and after sequential additions of 2-
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deoxyglucose (2-DG), oligomycin (Oligo), carbonyl cyanide-4-
(trifluoromethoxy)phenylhydrazone (FCCP), and a mixture of rotenone and antimycin A 
(Rot/AA), at the times indicated. Data represent the mean ±SEM (n=8 or 9 wells). D and E, 
TMRM fluorescence measurements with permeabilized wild-type HAP1 and HAP1-A12 cells, 
respectively, normalized to zero after the addition of succinate and to 1 following FCCP 
treatment; 5 mM glutamate and 2.5 mM malate (G-M), 0.1 mM ADP; 1 μM oligomycin 
(Oligo), 1 μM rotenone (Rot), 10 mM succinate (Suc), and 1 μM FCCP were added as 
indicated. 
 
 
Fig. S5. Comparison of the efficiency of staining of HAP1 wild-type cells and HAP1-A12 cells 
by calcein and TMRM. Grey and white histograms correspond to cells stained with calcein 
and/or TMRM, respectively. The percentage of fluorescent cells was determined with a 
Nucleocounter 3000. All data are the mean values  SDs (n=4). 
Table S3. Number of calcium pulses recorded in permeabilized wild-type HAP1 cells. 
The values in the first row refer to Fig. 4A and 4B. Rows 2-9 correspond to replicate 
experiments. 
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No CsA With CsA  Ratio 
7 20 2.86 
6 26 4.33 
5 13 2.6 
11 25 2.27 
7 21 3.0 
11 30 2.86 
7 21 3.0 
7 21 3.0 
5 11 2.2 
Av. 7.3 Av. 20.9 Av. 2.89 
SD. 2.2 SD. 6.0 SD. 0.62 
 
Table S4. Number of calcium pulses recorded in permeabilized HAP1-A12 cells. 
The values in the first row refer to Fig. 4D and 4E. Rows 2-4 correspond to replicate 
experiments. 
No CsA With CsA  Ratio 
8 21 2.63 
14 40 2.86 
9 18 2.0 
7 17 2.43 
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Av. 9.5 Av. 24.0 Av. 2.48 
SD. 3.1 SD. 10.8 SD. 0.36 
 
 
Fig. S6. Effects on protein relative abundance of the deletion of the c-subunit of human ATP 
synthase in HAP1 cells, and of the removal of ATP6 and ATP8 in 143B ρ0 cells. Relative 
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quantitative mass spectrometry analyses of proteins in mitoplasts (parts A and C) and purified 
ATP synthase (parts B and D) prepared from a 1:1 mixture of cells that were differentially 
SILAC-labelled. Panels A and B show the analyses of wild-type HAP1 cells combined with 
HAP1-A12 cells devoid of the ATP synthase c-subunit, and C and D the data from wild-type 
143B ρ+ cells and ρ0 cells lacking mitochondrial DNA. The experiments were performed twice, 
using reciprocal SILAC labelling orientations. For all the scatter plots each data point 
corresponds to the relative abundance ratio of an identified protein from the two 
complementary labelling experiments. ●, ATP synthase subunits and the precursor (P), or the 
M1 mature form of IF1; ●, all other identified proteins. Protein ratios and peptide evidence for 
IF1 are listed in Tables S5 to S12. 
 
Fig. S7. Sequences of the precursor and mature forms of the inhibitor protein IF1 and isoforms 
of subunit f of the human mitochondrial ATP synthase. The asterisks denote that the initiator 
methionine residue has been removed, and residue alanine-2 has been Nα-acetylated. A, 
residues 1-60 of the initial precursor form of IF1 (top line) and formation of IF1-P, and below 
the observed mature forms IF1-M1 and IF1-M2; B, complete sequences of isoforms f-1 and f-
2. They arise by an alternative splicing mechanism, and differ in the region denoted by shading 
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and dashes. Both isoforms were observed in mass spectrometric analyses. Subunit f lacks a 
processed N-terminal mitochondrial import sequence. 
 
 
Fig. S8. Presence of the PTP in human 143B cells. A, and B, + and 0 cells. Retention ratios 
in 143B cells for calcein (grey) and TMRM (white). The cells were treated with 20 M 
thapsigargin (TG) or 25 M ferutinin (FT) for 1 h, respectively, with or without CsA (5 M). 
TG activated cells were treated with CsA before staining whereas the FT cells were stained 
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with calcein and TMRM, and then treated with CsA. All ratios were normalized to the untreated 
143B cells (loaded with DMSO vehicle). The data represent means  SDs (TG, n=4; FT, n=2). 
 
 
Fig. S9. Structure of the c8-ring from bovine ATP synthase. As the sequences of the bovine 
and human c-subunits are the same, the structures of their c8-rings are identical. A, cross-
section of the ring showing concentric annuli of N- and C-terminal transmembrane α-helices; 
B, external view of the surface of the intact ring (inner and outer yellow and grey rings, 
respectively); C, internal view of the surface of half of the ring (four c-subunits). In the inner 
ring, yellow, pink, red and blue regions denote hydrophobic, hydrophilic, basic and acidic 
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residues, respectively; D, view of the region of contact between the c8-ring (below) and foot of 
the central stalk, in the enzyme’s rotor. Blue, green and magenta areas are parts of the γ-, δ- 
and ε-subunits. The c8-ring is grey. The red box indicates a small crevice in the model at 3.5 Å 
resolution leading to the central cavity. In reality, the crevice is probably occupied by the side 
chains of amino acids, which were truncated at the β-carbon atom in the model. 
 
Fig. S10. Optimisation of thapsigargin concentrations on the opening of the PTP in wild-type 
HAP1 cells. A, the cells were stained with both calcein and TMRM, then incubated for 1 h 
with various concentrations of thapsigargin. Grey and white columns represent the retention 
ratios for calcein and TMRM fluorescence signals, respectively, relative to untreated cells. B, 
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HAP1 cell viability after treatment with thapsigargin for 1 h was assessed by both trypan blue 
and propidium iodide staining, with a Countess-II FL automated cell counter (Thermo Fisher 
Scientific) or a NC3000 advanced image cytometer (ChemoMetec), respectively. The values 
are expressed relative to untreated HAP1 cells.   
 
Fig. S11. Cyclosporin A concentration dependent inhibition of the PTP in wild-type HAP1 
cells. Cells were stained with both calcein and TMRM, then pre-incubated with different 
concentrations of CsA or CsH for 5 min, and then treated for 1 h with 40 μM thapsigargin (A) 
or 25 μM ferutinin (B). The fluorescence retention ratio for calcein and TMRM was 
determined, relative to untreated cells. Grey and white columns difference values (CsA minus 
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CsH) for calcein and TMRM fluorescence signals, respectively. 
 
 
Fig. S12. An example of scatter plots used in the assay of the PTP. HAP1-A12 (A12) and 
HAP1 wild-type (WT) cells were stained with both calcein and TMRM. Then both sets of cells 
were incubated for 1 h in the presence of 25 µM ferutinin (FT) or DMSO vehicle, respectively. 
Green and red fluorescence intensities of calcein and TMRM, respectively, of samples of 5000 
cells with or without treatment with ferutinin were measured in a Nucleocounter NC3000 cell 
counting fluorescence microscope (ChemoMetec). Then, orthogonal axes were drawn 
manually on the 2D scatter plots for the WT cells and then used as the master template for the 
scatter plots for the HAP1-A12 cells. The relative calcein retention ratio was calculated as the 
ratio of HAP1-A12 positive percentages (the sum of the two percentages in the upper quadrants 
for A12: 7+3%=10%) and the positive percentages for wild-type cells (WT) (the sum of the 
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two percentages in the corresponding upper quadrants: 90+2%=92%). The values of intensities 
on both axes should be multiplied by 103. 
 
Supplementary Table S5. Proteins identified in SILAC experiments comparing 
immunopurifed ATP synthase from wild-type and HAP1-A12 cells. 
Supplementary Table S6. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing ATP synthase from wild-type and HAP1-A12 cells. 
Supplementary Table S7. Proteins identified in SILAC experiments comparing 
immunopurified ATP synthase from wild-type and 143B ρ0 cells. 
Supplementary Table S8. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing ATP synthase from wild-type and ρ0 143B cells. 
Supplementary Table S9. Proteins identified in SILAC experiments comparing mitoplasts 
from wild-type and HAP1-A12 cells. 
Supplementary Table S10. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing mitoplasts from wild-type and HAP1-A12 cells. 
Supplementary Table S11. Proteins identified in SILAC experiments comparing mitoplast 
material from wild-type and 143B ρ0 cells. 
Supplementary Table S12. Peptide data for the ATPase inhibitor protein obtained in SILAC 
experiments comparing mitoplasts from wild-type and 143B ρ0 cells. 
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